Springboard Health Angels

At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10 million patients with metastatic cancer.​ Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed.

Vivalyx is a healthcare company focused on improving organ transplantation outcomes. It specializes in developing a cost-effective solution for preserving organs, aiming to enhance their vitality and increase the available number for transplantation. The company's technology eliminates the need for donor blood or human products, making it a versatile option for various preservation applications. By doing so, Vivalyx supports doctors in extending organ viability, ultimately benefiting patients suffering from organ failure worldwide.

Yoneda Labs is a developer of AI-based software designed to assist chemists in optimizing reaction parameters essential for the synthesis of drugs and materials. The platform enables users to determine critical factors such as temperature, concentration, and catalyst, thereby enhancing the efficiency and speed of chemical laboratory processes. By leveraging advanced artificial intelligence, Yoneda Labs aims to streamline the development of chemical reactions, ultimately facilitating faster innovation in the pharmaceutical and material sciences industries.

deepeye is a company that develops an AI-powered precision medicine platform for retinal diseases. The platform enables ophthalmologists to tailor therapies for conditions such as age-related macular degeneration and other retinal disorders by analyzing therapy data and providing second opinions on treatment needs and scheduling. It serves clinicians, pharmaceutical developers, payors, and provider associations to improve therapy outcomes and prevent vision loss.

PharmaCCX is a healthcare technology company established in 2017, headquartered in Boston with additional offices in Stockholm, San Mateo, and Zug. It operates a platform that facilitates pricing negotiations and procurement processes between oncology pharmaceutical companies and healthcare payers, aiming to accelerate patient access to necessary medicines. The platform offers a configurable infrastructure for planning, negotiating, and managing deals, enabling market access teams at pharma companies and payers to efficiently administer innovative payment models.

Tech-enabled healthcare solution for the underserved LGBTQIA+ community.

LEVY Health specializes in clinical decision support software focused on endocrine disorders. Its platform employs proprietary algorithms and clinical guidelines to recommend ICD-10 diagnoses and individual therapeutic strategies, reducing the average time to diagnosis from approximately four years to just a few weeks.

Virtonomy GmbH is a Munich-based company that specializes in providing clinical trial services using virtual human, sheep, pig, and calf models. Founded in 2019, Virtonomy offers a platform that integrates digital twin models, AI, multi-physics simulations, and predictive analytics to enhance the development and evaluation of medical devices. The company delivers services such as anatomy studies, virtual fittings, pre-operative planning, and visualization through detailed image analysis and three-dimensional anatomical models. By enabling medical device manufacturers to optimize designs, reduce risks associated with anatomical variability, and develop patient-specific implants, Virtonomy facilitates a streamlined product development process. This approach not only shortens development timelines but also minimizes costs and risks linked to traditional clinical trials, allowing for safer and more efficient testing in a virtual environment.

Developer of the world's first cell-based platform for designing, optimizing, and manufacturing pure, non-immunogenic messenger RNA (mRNA) for next-generation mRNA medicines. The company uses cell engineering, computational biology, and precision fermentation to enhance vaccine production.

Acorai is a medical device company focused on developing a non-invasive heart failure monitoring platform that centers around direct intracardiac pressure monitoring (ICPM). The company utilizes a unique combination of sensor technologies and machine learning to enable accurate and cost-effective heart failure management. Acorai's technology allows for the non-invasive monitoring of cardiac and pulmonary pressure through the analysis of acoustic, vibratory, and waveform data, making it the only proven method to enhance outcomes for heart failure patients. The device has received clinical validation and has been designated as an FDA Breakthrough Device, with plans to enter the market in 2025. By enabling healthcare professionals to proactively adjust medications, Acorai aims to reduce both the rates of heart failure re-hospitalization and mortality.

Syndi is a digital health support recommendation platform that utilizes machine learning and digital phenotyping, with a primary focus on mental health. The company develops technology-driven solutions aimed at enhancing individuals' health by providing effective and accessible support. Syndi's platform employs passive smartphone data collection to gather moment-to-moment information about users, allowing it to deliver personalized and immediate care. This innovative approach not only facilitates connections between patients and healthcare providers but also measures the effectiveness of applications and digital services in treating invisible disabilities. Through its commitment to leveraging technology and research, Syndi seeks to improve healthcare outcomes for its users.

Recovery Cat provides a therapy collaboration platform for patients with severe mental disorders, enabling collective therapy planning and evaluation and delivering insights to doctors and patients by monitoring responses to treatments for schizophrenia, bipolar disorder and recurrent depression, helping psychiatrists tailor medications, identify at-risk patients, and support engagement to prevent relapses through personalized follow-ups and data-driven insights.

Mirantus Health is a digital healthcare provider focused on enhancing access to care for underserved patients. It offers a combination of healthcare services through Mirantus Care and cloud-based solutions via Mirantus OS, which empower physicians to efficiently diagnose and treat patients who are traditionally hard to reach. By integrating point-of-care diagnostics with telemedicine, Mirantus enables specialist physicians to deliver care remotely, thus improving healthcare accessibility. The company aims to involve every specialist physician in Europe in its distributed healthcare model, ultimately striving to provide better access to care for over 100 million underserved patients while also helping physicians increase their earnings and reducing downstream costs for payors.

Akina is a Swiss company founded in 2021, headquartered in Zurich, that specializes in developing artificial intelligence healthcare software. The company focuses on enhancing physiotherapy by providing a platform that empowers patients to engage in independent therapy at home. Through its innovative software, Akina connects patients with healthcare providers for remote therapeutic monitoring and personalized guidance. The platform utilizes proprietary AI motion analysis and media streaming algorithms to facilitate automated case reviews and generate feedback for therapists. This approach aims to improve clinical outcomes and enhance the efficiency of care delivery, merging evidence-based therapy with engaging entertainment for a comprehensive treatment experience.

Phinomics is a precision-medicine company specializing in circular-DNA targets for personalized healthcare. It employs reproducible science, novel technologies, proprietary workflows, informatics/AI, and single-cell analysis to identify and validate unique pathology-specific circular-DNAs, addressing unmet clinical needs with high resolution.

Rekoo is an online clinic for stroke healing. They provide optimal care for every stroke patient by returning them to the center. They offer care systems, but they don't find the support they need, resulting in deficient recovery outcomes and skyrocketing care costs.